Neurocognitive Aspects of Medication Adherence in HIV Infection
- 1 December 2002
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 31, S132-S135
- https://doi.org/10.1097/00126334-200212153-00009
Abstract
Strict adherence to the current highly active antiretroviral therapies (HAART) is a prerequisite for treatment success. The complexities of the treatment regimens places high demands on motivational and cognitive factors, and studies of cognitive predictors of adherence are just beginning to emerge. Traditional measures of new learning and recall may not be among the best neuropsychologic predictors of adherence. Rather, certain aspects of frontal and executive functioning appear to be more strongly associated with good adherence.Keywords
This publication has 22 references indexed in Scilit:
- HIV-associated cognitive impairment before and after the advent of combination therapyJournal of NeuroVirology, 2002
- AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapyAIDS, 2001
- Problem drinking and medication adherence among persons with HIV infectionJournal of General Internal Medicine, 2001
- Medication adherence among HIV-infected patients: Understanding the complex behavior of patients taking this complex therapyCurrent Infectious Disease Reports, 1999
- Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individualsThe Journal of Neuropsychiatry and Clinical Neurosciences, 1997
- Cognitive performance after progression to AIDSNeurology, 1995
- Compliance and Cognitive Function: A Methodological Approach to Measuring Unintentional Errors in Medication Compliance in the ElderlyThe Gerontologist, 1993
- Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virusThe Journal of Neuropsychiatry and Clinical Neurosciences, 1993
- Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus‐type 1 (HIV‐1) infectionNeurology, 1991
- HIV‐1 infectionNeurology, 1990